Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Potent, selective c-Src TK inhibitor identified using new target-based method

March 16, 2000

Medarex and Regeneron form human antibody drug collaboration

March 15, 2000

3-D and Boehringer Ingelheim enter R&D collaboration

March 15, 2000

Corixa, QLT team up to expand the possibilities of photodynamic therapy

March 10, 2000

Millennium gains broad access to XenoMouse technology

March 10, 2000

Patent broadens protection for Endorex's oral/mucosal drug delivery system

March 8, 2000

Immunomedics successfully delivers cancer drug through bispecific fusion proteins

March 8, 2000

Gelkem and Ethypharm to jointly develop controlled-release drugs

March 7, 2000

New use patents expand coverage for Aradigm's pulmonary drug delivery system

March 7, 2000

Phase II SBIR grant awarded to 3-D for GPCRs

March 6, 2000

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...